Pharmaceutical Solvent Recovery Processes in Bulk Drug Manufacturing offer a comprehensive solution for reclaiming valuable solvents during active pharmaceutical ingredient (API) production. Identification details for this product include its CAS number, molecular formula, and molecular weight, ensuring clarity and traceability in compliance-driven environments. Its chemical identity is further established by inclusion of its IUPAC designation and InChIKey, which support unambiguous cataloging and facilitate regulatory documentation. This product is specifically categorized as a process technology or reagent within the pharmaceutical manufacturing supply chain.
Physical and chemical specifications are essential for operational integration and process design. All available data on melting point, boiling point, density, flash point, and vapor pressure inform safe handling and optimal performance in an industrial context. These attributes contribute to proper selection of recovery apparatus and ensure stability across various stages of bulk drug manufacturing, while helping users anticipate potential risks during solvent handling.
Compliance is assured with a rigorous approach to regulatory alignment. Solvent recovery processes must conform to established standards, including REACH registration data referencing article numbers and applicable tonnage bands. United States TSCA status, provided with its corresponding section reference, demonstrates eligibility for commercial distribution and use within the American market. Global harmonization is supported through reference to ICH Q3C(R8), which defines residual solvent risk assessments and specifies permitted concentration thresholds. The product’s hazard profile aligns with the Globally Harmonized System (GHS), communicating all required signal words and H-phrases to support workplace safety and hazard communication. Further details include references to applicable pharmacopeia chapters for monograph-based acceptance, in addition to OSHA and NIOSH workplace exposure limits where relevant.
In terms of application, solvent recovery processes occupy a central role in bulk drug synthesis, where cost-control and sustainability objectives heavily favor solvent reclamation. These processes are widely employed in the manufacture of intermediates and finished APIs. Practical examples include the recovery of common organics used in the synthesis of antibiotics, analgesics, and various other high-value therapeutics. Implementation supports both green chemistry initiatives and regulatory mandates for waste reduction, without making claims regarding the clinical efficacy of any resulting pharmaceutical compounds.
For packaging and storage, solvent recovery solutions are typically supplied in robust, industry-appropriate vessels. Standard offerings may include 25 kilogram drums for pilot-scale operations, 200 kilogram containers for bulk applications, and intermediate bulk containers (IBCs) for high-volume requirements. Optimal storage relies on recommendations derived from established GHS stability data, emphasizing cool, dry, and well-ventilated facilities to preserve efficiency and minimize degradation risks. Shelf life guidance follows industry norms for this chemical class, supporting secure inventory management and predictable recycling performance.
Key references for further detail and verification include PubChem, the NIST Chemistry WebBook, the European Chemicals Agency website, and the EPA’s TSCA Inventory, allowing researchers and quality assurance professionals to validate specifications and compliance with confidence.
Sources
https://pubchem.ncbi.nlm.nih.gov/compound/
https://webbook.nist.gov/cgi/cbook.cgi?Name=
https://www.epa.gov/tsca-inventory
Related Articles
